Brand Names and Availability Tirzepatide is marketed as Mounjaro for type 2 diabetes and Zepbound for weight loss
Common reported side effects include nausea, vomiting, constipation, diarrhea, reduced appetite, and unusual skin sensations
Good options include kefir (especially effective for constipation), sauerkraut, kimchi, yogurt with live cultures, and miso
GLP-1 drugs work by: Increasing insulin secretion Decreasing glucagon release Enhancing feelings of fullness through the brains signaling pathways Common GLP-1 Drugs on the Market There are several well-known Gastroparesis available today, each with its own specific formulation and manufacturer: Semaglutide-Based Medications: Ozempic : Made by Novo Nordisk, approved for managing type 2 diabetes with a once-weekly injection under the skin Wegovy : Also produced by Novo Nordisk, specifically approved for long-term weight management in adults with obesity or overweight conditions along with weight-related health issues Tirzepatide-Based Medications: Mounjaro : Created by Eli Lilly, approved for treating type 2 diabetes as a dual GIP/GLP-1 receptor agonist Zepbound : Eli Lillys formulation specifically indicated for chronic weight management Off-Label Prescribing Practices Medical Gaps: Theres often a gap between what these medications are officially approved for and how they are actually being prescribed in practice
For Ozempic-specific food help, read best foods to eat on Ozempic
